Popovic Dusanka, Kulas Jelena, Tucovic Dina, Popov Aleksandrov Aleksandra, Malesevic Anastasija, Glamoclija Jasmina, Brdaric Emilija, Sokovic Bajic Svetlana, Golic Natasa, Mirkov Ivana, Tolinacki Maja
Immunotoxicology Group, Department of Ecology, Institute for Biological Research "Sinisa Stankovic" - National Institute of the Republic of Serbia, University of Belgrade , Belgrade, Serbia.
Mycology Laboratory, Department of Plant Physiology, Institute for Biological Research "Sinisa Stankovic" - National Institute of the Republic of Serbia, University of Belgrade , Belgrade, Serbia.
Microbiol Spectr. 2023 Aug 25;11(5):e0199023. doi: 10.1128/spectrum.01990-23.
While the effect of gut microbiota and/or inflammation on a distant body site, including the lungs (gut-lung axis), has been well characterized, data about the influence of lung microbiota and lung inflammation on gut homeostasis (lung-gut axis) are scarce. Using a well-characterized model of pulmonary infection with the fungus , we investigated alterations in the lung and gut microbiota by next-generation sequencing of the V3-V4 regions of total bacterial DNA. Pulmonary inflammation due to the fungus caused bacterial dysbiosis in both lungs and gut, but with different characteristics. While increased alpha diversity and unchanged bacterial composition were noted in the lungs, dysbiosis in the gut was characterized by decreased alpha diversity indices and modified bacterial composition. The altered homeostasis in the lungs allows the immigration of new bacterial species of which 41.8% were found in the feces, indicating that some degree of bacterial migration from the gut to the lungs occurs. On the contrary, the dysbiosis occurring in the gut during pulmonary infection was a consequence of the local activity of the immune system. In addition, the alteration of gut microbiota in response to pulmonary infection depends on the bacterial composition before infection, as no changes in gut bacterial microbiota were detected in a rat strain with diverse gut bacteria. The data presented support the existence of the lung-gut axis and provide additional insight into this mechanism. IMPORTANCE Data regarding the impact of lung inflammation and lung microbiota on GIT are scarce, and the mechanisms of this interaction are still unknown. Using a well-characterized model of pulmonary infection caused by the opportunistic fungus , we observed bacterial dysbiosis in both the lungs and gut that supports the existence of the lung-gut axis.
虽然肠道微生物群和/或炎症对包括肺部在内的远处身体部位(肠-肺轴)的影响已得到充分表征,但关于肺部微生物群和肺部炎症对肠道稳态(肺-肠轴)影响的数据却很稀少。我们使用一种特征明确的肺部真菌感染模型,通过对总细菌DNA的V3-V4区域进行下一代测序,研究了肺部和肠道微生物群的变化。由该真菌引起的肺部炎症导致肺部和肠道细菌群落失调,但具有不同特征。虽然肺部的α多样性增加且细菌组成未改变,但肠道的失调表现为α多样性指数降低和细菌组成改变。肺部内稳态的改变使得新的细菌物种得以迁入,其中41.8%可在粪便中发现,这表明存在一定程度的细菌从肠道向肺部迁移。相反,肺部感染期间肠道发生的失调是免疫系统局部活动的结果。此外,肠道微生物群对肺部感染的反应变化取决于感染前的细菌组成,因为在具有不同肠道细菌的大鼠品系中未检测到肠道细菌微生物群的变化。所呈现的数据支持肺-肠轴的存在,并为这一机制提供了更多见解。重要性关于肺部炎症和肺部微生物群对胃肠道影响的数据很少,这种相互作用的机制仍然未知。使用一种由机会性真菌引起的特征明确肺部感染模型,我们观察到肺部和肠道的细菌群落失调,这支持了肺-肠轴的存在。